Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATTH: Parathyroid Allotransplant for Hypoparathyroidism
NCT06961071Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of parathyroid allotransplant in hypoparathyroidism. Started Jan 2026; status: recruiting.
02
Drugs
parathyroid allotransplant
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT06961071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06961071.